Why the study?
Cardiac physiologic pacing has emerged to mitigate or prevent heart failure from ventricular dyssynchrony or pacing-induced cardiomyopathy, creating a need for clinical guidance across indications, implantation, and management.
This 2023 joint society guideline provides comprehensive recommendations on the use of cardiac physiologic pacing, including CRT and conduction system pacing, to prevent or mitigate heart failure.
Provides first dedicated CPP guidance for HF prevention in dyssynchrony; extends CRT indications to include conduction system pacing.
Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT) and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may mitigate or prevent the development of heart failure (HF) in patients with ventricular dyssynchrony or pacing-induced cardiomyopathy. This clinical practice guideline is intended to provide guidance on indications for CRT for HF therapy and CPP in patients with pacemaker indications or HF, patient selection, pre-procedure evaluation and preparation, implant procedure management, follow-up evaluation and optimization of CPP response, and use in pediatric populations. Gaps in knowledge, pointing to new directions for future research, are also identified.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: